PriceTargets.com logo

Chr. Hansen Holding A/S - CHYHY Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$19.59 As of 02/26/2024 10:05 PM ET
▲ +0.165 (0.85%)

This chart shows the closing price for CHYHY by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Chr. Hansen Holding A/S Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CHYHY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CHYHY

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Chr. Hansen Holding A/S in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $19.59.

This chart shows the closing price for CHYHY for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in Chr. Hansen Holding A/S. This rating has held steady since September 2024, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 1 strong buy ratings
  • 1 buy ratings
  • 7 hold ratings
  • 0 sell ratings
Ratings as of
6/27/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 7 hold ratings
  • 0 sell ratings
Ratings as of
9/25/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
12/24/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/23/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/21/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/19/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/18/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/18/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/10/2023DNB MarketsUpgradeHold ➝ Buy
8/10/2023DNB MarketsDowngradeBuy ➝ Hold
1/13/2023BarclaysLower TargetEqual Weight ➝ Equal Weight550.00 ➝ 525.00
1/6/2023Credit Suisse GroupBoost TargetNeutral ➝ Neutral455.00 ➝ 475.00
12/28/2022DNB MarketsUpgradeHold ➝ Buy
12/15/2022BarclaysBoost TargetEqual Weight ➝ Equal Weight475.00 ➝ 550.00
12/13/2022Exane BNP ParibasUpgradeUnderperform ➝ Neutral
12/13/2022BNP ParibasUpgradeNeutral
12/13/2022DNB MarketsDowngradeBuy ➝ Hold
12/12/2022Jefferies Financial GroupUpgradeUnderperform ➝ Hold
12/5/2022JPMorgan Chase & Co.Boost Target415.00 ➝ 460.00
10/17/2022JPMorgan Chase & Co.Lower TargetNeutral ➝ Neutral455.00 ➝ 415.00
10/13/2022BarclaysBoost TargetEqual Weight ➝ Equal Weight460.00 ➝ 475.00
10/5/2022BarclaysLower Target550.00 ➝ 460.00
9/14/2022Jefferies Financial GroupInitiated CoverageUnderperform
9/1/2022The Goldman Sachs GroupUpgradeNeutral ➝ Conviction-Buy
8/23/2022Exane BNP ParibasDowngradeNeutral ➝ Underperform
7/12/2022Credit Suisse GroupLower TargetNeutral ➝ Neutral550.00 ➝ 500.00
7/12/2022Berenberg BankLower TargetHold ➝ Hold570.00 ➝ 510.00
6/28/2022BarclaysBoost TargetEqual Weight ➝ Equal Weight550.00 ➝ 560.00
4/7/2022Credit Suisse GroupBoost TargetNeutral ➝ Neutral530.00 ➝ 550.00
3/29/2022BarclaysLower TargetEqual Weight ➝ Equal Weight550.00 ➝ 540.00
1/18/2022JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral$515.00 ➝ $535.00
1/4/2022BarclaysUpgradeUnderweight ➝ Equal Weight
11/30/2021JPMorgan Chase & Co.Reiterated RatingUnderweight
10/18/2021BarclaysReiterated RatingUnderweight
10/18/2021JPMorgan Chase & Co.Reiterated RatingUnderweight
10/18/2021UBS GroupReiterated RatingNeutral
10/15/2021Credit Suisse GroupReiterated RatingNeutral
7/13/2021BarclaysReiterated RatingUnderweight
7/13/2021JPMorgan Chase & Co.Reiterated RatingUnderweight
7/12/2021Berenberg BankSet TargetHold$22.54
7/9/2021UBS GroupReiterated RatingNeutral
6/11/2021BarclaysReiterated RatingUnderweight
4/19/2021Berenberg BankReiterated RatingHold
4/14/2021UBS GroupReiterated RatingNeutral
1/15/2021BarclaysReiterated RatingUnderweight
1/15/2021DNB MarketsUpgradeSell ➝ Hold
1/7/2021DanskeUpgradeHold ➝ Buy
12/3/2020JPMorgan Chase & Co.Reiterated RatingUnderweight
12/1/2020UBS GroupReiterated RatingNeutral
11/18/2020BarclaysInitiated CoverageUnderweight
10/20/2020The Goldman Sachs GroupUpgradeSell ➝ Neutral
10/13/2020JPMorgan Chase & Co.Reiterated RatingUnderweight
10/13/2020Credit Suisse GroupReiterated RatingNeutral
7/28/2020Bank of AmericaDowngradeNeutral ➝ Underperform
7/13/2020JPMorgan Chase & Co.Reiterated RatingUnderweight
7/8/2020UBS GroupReiterated RatingNeutral
7/6/2020Berenberg BankReiterated RatingHold
7/3/2020DanskeDowngradeBuy ➝ Hold
6/15/2020Berenberg BankReiterated RatingHold
1/17/2020BarclaysDowngradeEqual Weight ➝ Underweight
1/8/2020The Goldman Sachs GroupInitiated CoverageSell
(Data available from 12/18/2019 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/22/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/21/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/21/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/20/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/19/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/19/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/18/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/18/2024

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Chr. Hansen Holding A/S logo
Chr. Hansen Holding A/S, a bioscience company, develops natural ingredient solutions for the food, nutritional, pharmaceutical, and agricultural industries in Europe, the Middle East, Africa, North America, Latin America, and the Asia Pacific. The company operates through Food Cultures & Enzymes, and Health & Nutrition segments. The Food Cultures & Enzymes segment produces and sells various cultures, enzymes, and probiotic products that determine the taste, flavor, texture, shelf life, nutritional value, and health benefits of various consumer products in the food industry, primarily in the dairy industry. The Health & Nutrition segment produces and sells products for the dietary supplement, over-the-counter pharmaceutical, infant formula, animal feed, and plant protection industries. It has a strategic collaboration with UPL Ltd. to develop and commercialize microbial-based bio solutions for sustainable agriculture. The company was founded in 1843 and is headquartered in Hørsholm, Denmark. As of January 29, 2024, Chr. Hansen Holding A/S operates as a subsidiary of Novozymes A/S.
Read More

Today's Range

Now: $19.59
Low: $19.42
High: $19.86

50 Day Range

MA: $19.59
Low: $19.59
High: $19.59

52 Week Range

Now: $19.59
Low: $14.73
High: $25.32

Volume

7,300 shs

Average Volume

13,855 shs

Market Capitalization

N/A

P/E Ratio

38.78

Dividend Yield

0.97%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Chr. Hansen Holding A/S?

The following equities research analysts have issued stock ratings on Chr. Hansen Holding A/S in the last year:
View the latest analyst ratings for CHYHY.

What is the current price target for Chr. Hansen Holding A/S?

0 Wall Street analysts have set twelve-month price targets for Chr. Hansen Holding A/S in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Chr. Hansen Holding A/S in the next year.
View the latest price targets for CHYHY.

What is the current consensus analyst rating for Chr. Hansen Holding A/S?

Chr. Hansen Holding A/S currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for CHYHY.

What other companies compete with Chr. Hansen Holding A/S?

Other companies that are similar to Chr. Hansen Holding A/S include AirBoss of America, Akzo Nobel, Alfa, ALPEK and Avantium. Learn More about companies similar to Chr. Hansen Holding A/S.

How do I contact Chr. Hansen Holding A/S's investor relations team?

Chr. Hansen Holding A/S's physical mailing address is Boege AllE 10-12, Horsholm 2970, Denmark. The company's listed phone number is (454) 574-7474. The official website for Chr. Hansen Holding A/S is www.chr-hansen.com. Learn More about contacing Chr. Hansen Holding A/S investor relations.